Continue active refreshing of this index's data?
Continue active refreshing of this index's data?
Thematic Investing
Most Recent Thematic Investing
Strong balance sheets, established businesses, higher return-on-equity and superior profitability.
Advancements in artificial intelligence (AI) have continued apace over the last few years. Thanks to improved connectivity, faster processing speeds and astounding developments in machine learning, AI is now part of our everyday life.
“Artificial Intelligence” in investing: index provider Stoxx runs a new methodology against a classic benchmark in an experiment (German language only)
This year STOXX Ltd. introduced two indices that give exposure to the growing theme of artificial intelligence (AI).
Index | Thematic Investing
STOXX Global Electric Vehicles & Driving Technology Index Licensed To BlackRock
STOXX Ltd. has licensed the STOXX® Global Electric Vehicles & Driving Technology Index to BlackRock to serve as an underlying for an ETF.
The McKinsey Global Institute writes that ‘artificial intelligence (AI) is poised to unleash the next wave of digital disruption.’
Much of the media coverage of artificial intelligence (AI) has been focusing, rightly so, on the fantastic new possibilities enabled by empowered, human-like computers.
The artificial intelligence (AI) revolution has penetrated most industries and services, with machines now handling an increasing number of tasks that only humans could once do.
While we tend to think of artificial intelligence (AI) as the future, the truth is the technology has already transformed asset managers’ core business beyond recognition.
STOXX Ltd. introduced the world’s first index that uses AI-related algorithms to select companies exposed to the artificial intelligence (AI) megatrend at the Inside ETFs conference in the U.S. The new index will be available as of 23 January 2018.
After a bumper year for equities, strategists are forecasting further gains for 2018, while pointing to risks from rising bond yields and higher volatility.
Whether it’s optimizers of patient treatment or hybrid bio-chemical drugs, many health-care stocks are inventing the future.